{{ window.visitor.corporateClient.name }}

Företagslösning

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}
Välkommen till vår företagslösning

Här kan du administrera användarna i din företagslösning.
Välkommen till din prenumeration för Medtech Magazine.
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Medtech Magazine.

Click here to go to sign-up

Annons

Innehållet nedan modereras inte i förväg och omfattas därmed inte av webbplatsens utgivningsbevis.

Dela sida

Sponsrat innehåll

Recent clarification in Sweden’s clinical trial legislation

From 1 July 2026, a clarification in the Swedish Medicines Act has further defined the role of legal representatives in clinical trials—specifically their responsibility to safeguard the individual’s personal interests.

While subtle, this update reinforces:

• Ethical oversight
• Patient protection
• Clear accountability in consent processes

These types of regulatory refinements are a key part of maintaining trust in clinical research.

At Aurevia, we help translate evolving regulations into practical approaches for clinical development.

Learn more